A new video features Juliette McGregor, an assistant professor of ophthalmology at the University of Rochester Medical Center, and explains common misunderstandings about blindness. The video looks at whether lost sight can be restored and why the question matters for daily life.
McGregor says blindness is best seen as a spectrum of visual impairment. The exact experience varies with which eye or brain structure is affected, the severity of the problem and a patient’s ability to adapt to the loss.
The video explains that treatments exist in many cases to reduce or prevent further vision loss. For other conditions medical options are limited and care focuses on assistive support, for example devices or training to help with daily activities. The balance between treatment and support depends on the type and stage of the condition.
Several laboratories at the University of Rochester study causes of vision loss and how retinal neurons break down. Many details remain unclear, and McGregor describes research directions and the scientific questions that still need answers. New treatments could be on the horizon, but it is not yet clear which will reach patients or when. Credit for the video and commentary goes to the University of Rochester; the item appeared on Futurity.
Difficult words
- blindness — complete or partial loss of sight
- spectrum — range of different forms or degrees
- severity — how serious a health problem is
- adapt — to change behaviour to new conditions
- assistive — helpful tools or services for daily tasks
- neuron — a nerve cell in the eye or brainneurons
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- How might seeing blindness as a spectrum change how doctors treat patients?
- What daily activities could devices or training help with for someone who has lost vision?
- Would you prefer a treatment that aims to stop vision loss or support that helps you adapt? Why?
Related articles
New inhaled nanoparticle treatment for tuberculosis
Researchers at the University at Buffalo developed inhalable nanoparticles that carry rifampin to lung immune cells. In mice the treatment kept drug levels in the lung much longer and may allow weekly dosing with fewer side effects.
January 2025 Los Angeles wildfires and the rise in virtual health visits
A study of 3.7 million Kaiser Permanente members found that the January 2025 Los Angeles wildfires caused large increases in virtual care, especially for respiratory and cardiovascular symptoms, and raised other outpatient visits.
